Remy Sukhija

2021

In 2021, Remy Sukhija earned a total compensation of $2.8M as Senior Vice President, Chief Commercial Officer at Synta Pharmaceuticals, a 19% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$248,436
Option Awards$2,048,400
Salary$461,250
Other$10,381
Total$2,768,467

Sukhija received $2M in option awards, accounting for 74% of the total pay in 2021.

Sukhija also received $248.4K in non-equity incentive plan, $461.3K in salary and $10.4K in other compensation.

Rankings

In 2021, Remy Sukhija's compensation ranked 4,750th out of 12,415 executives tracked by ExecPay. In other words, Sukhija earned more than 61.7% of executives.

ClassificationRankingPercentile
All
4,750
out of 12,415
62nd
Division
Manufacturing
1,976
out of 5,505
64th
Major group
Chemicals And Allied Products
832
out of 2,375
65th
Industry group
Drugs
745
out of 2,096
65th
Industry
Pharmaceutical Preparations
533
out of 1,546
66th

Pay ratio

Remy Sukhija's Pay$2,768,467
Median Employee's Pay$459,419
Pay Ratio

6

to 1

In 2021, the annual total compensation of Remy Sukhija was $2,768,467.

The annual total compensation of the median employee at Synta Pharmaceuticals was $459,419.

The ratio of Remy Sukhija's pay to the pay of median employee was therefore 6 to one.

Source: SEC filing on May 2, 2022.

Sukhija's colleagues

We found five more compensation records of executives who worked with Remy Sukhija at Synta Pharmaceuticals in 2021.

2021

Alex Howarth

Synta Pharmaceuticals

Chief Financial Officer

2021

Paul Friedman

Synta Pharmaceuticals

Chief Executive Officer

2021

Rebecca Taub

Synta Pharmaceuticals

Chief Medical Officer

2021

Marc Schneebaum

Synta Pharmaceuticals

Chief Financial Officer

2021

Brian Lynch

Synta Pharmaceuticals

General Counsel

News

In-depth

You may also like